deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT07058636

Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain

Evaluation of the Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain and Upper Trapezius Trigger Points: A Single-Blind Randomized Controlled Trial

Sponsor: Ankara Etlik City Hospital

Conditions Cervicogenic Headache Myofacial Pain Syndrome Neck Pain Trigger Point Pain, Myofascial Trigger Points Upper Trapezius Trigger Points
Interventions 2% Lidocaine HCl + saline Steroid+lidocaine
Updated 2 times since 2025 Last updated: Jul 1, 2025 Started: Apr 3, 2025 Primary completion: Mar 31, 2026 Completion: Apr 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07058636, this NA trial focuses on Cervicogenic Headache and Myofacial Pain Syndrome and remains actively recruiting participants. Sponsored by Ankara Etlik City Hospital, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting NA

  2. Aug 2025 — Sep 2025 [monthly]

    Recruiting NA

    First recorded

Apr 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ankara Etlik City Hospital
Data source: Ankara Etlik City Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations